Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Structural elucidation of IKs activators bound to ion channel complexes

FY 2020-21

Summary
Irregular heartbeat disorders, known as arrhythmias, present a severe strain on the healthcare system, can greatly lower patient quality of life and may result in sudden death. KCNQ1 is a voltage-gated potassium ion channel that serves an essential function in the maintenance of cardiac rhythm through the repolarizing action of the slow-delayed rectifier potassium current (IKs). Mutations of the KCNQ1 gene that cause a loss-of-function of IKs are implicated in a wide array of arrhythmias, including long QT-interval syndrome (LQTS). Thus, IKs activator drugs which bind KCNQ1 are a potential therapeutic option for LQTS, and while a number of these have been reported, their mechanisms of action are poorly understood. Here we propose using cryogenic-Electron microscopy (cryo-EM) to probe the actions of the archetypal agonists, ML277 and polyunsaturated fatty acids (PUFAs) on the IKs ion channel complex. Cryo-EM is a revolutionary advancement in protein structure determination, capable of achieving high resolution 3D images of protein-drug interactions by bombarding a frozen solution of purified protein with electrons. We have already begun to use cryo-EM to visualize KCNQ1-protein complexes, and so we are equipped with an optimized protocol to achieve our goals. We will also perform functional studies of the KCNQ1-ML277 complex to understand the relationship between drug binding and subsequent channel effects. The determination of a structural model of this complex will facilitate a better understanding of how IKs activators change the kinetic properties of KCNQ1, paving the way for the development of new drugs to treat LQTS, and improve our understanding of mechanisms that modulate IKs through binding to KCNQ1.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
449466
Name
Russo Sophia C
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Structural elucidation of IKs activators bound to ion channel complexes
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Arrythmias; Cardiology; Cryo-Electron Microscopy; Drug Development; Iks Activators; Kcnq1; Long Qt-Interval Syndrome; Ml277; Slow-Delayed Rectifier Current; Structure Determination
Abstract
Irregular heartbeat disorders, known as arrhythmias, present a severe strain on the healthcare system, can greatly lower patient quality of life and may result in sudden death. KCNQ1 is a voltage-gated potassium ion channel that serves an essential function in the maintenance of cardiac rhythm through the repolarizing action of the slow-delayed rectifier potassium current (I<sub>Ks</sub>). Mutations of the KCNQ1 gene that cause a loss-of-function of I<sub>Ks</sub> are implicated in a wide array of arrhythmias, including long QT-interval syndrome (LQTS). Thus, I<sub>Ks</sub> activator drugs which bind KCNQ1 are a potential therapeutic option for LQTS, and while a number of these have been reported, their mechanisms of action are poorly understood. Here we propose using cryogenic-Electron microscopy (cryo-EM) to probe the actions of the archetypal agonists, ML277 and polyunsaturated fatty acids (PUFAs) on the I<sub>Ks</sub> ion channel complex. Cryo-EM is a revolutionary advancement in protein structure determination, capable of achieving high resolution 3D images of protein-drug interactions by bombarding a frozen solution of purified protein with electrons. We have already begun to use cryo-EM to visualize KCNQ1-protein complexes, and so we are equipped with an optimized protocol to achieve our goals. We will also perform functional studies of the KCNQ1-ML277 complex to understand the relationship between drug binding and subsequent channel effects. The determination of a structural model of this complex will facilitate a better understanding of how I<sub>Ks</sub> activators change the kinetic properties of KCNQ1, paving the way for the development of new drugs to treat LQTS, and improve our understanding of mechanisms that modulate I<sub>Ks</sub> through binding to KCNQ1.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Russo, Sophia C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~